on 29 Feb 2012
Last Applicant/ Owned by
Accentia Biopharmaceuticals, Inc.
324 S. Hyde Park Ave., Suite 350
Tampa,, , 33606
Serial Number
UK00910686021 filed on 29th Feb 2012
Registration Number
UK00910686021 registered on
1st Nov 2012
Correspondent Information
Gill Jennings & Every LLP
The Broadgate Tower, 20 Primrose Street
London,
EC2A 2ES
Administering a regulatory compliance program to maximize clinical benefit and minimize risk in treating patients suffering from immune disorders and malignancies with pharmaceuticals, namely oxazaphosphorine drugs, consisting of maintaining a medical registry and providing interactive record keeping services and medication guide to ensure the safe and effective prescribing and dispensing of oxazaphosphorine pharmaceuticals.
Education; providing of training.
Medical services; hygienic and beauty care for human beings or animals; medical analysis for the diagnosis and treatment of persons; pharmacy advice; providing a communication plan to ensure patient counseling, education, and input on safe and effective use of oxazaphosphorine pharmaceuticals for the treating physicians and pharmacists, conducting pre-therapy screening for existing conditions and screening for potential drug interactions, and providing diagnostic tests and regimens for prophylactic agents, tests and treatments intended to minimize the potential of infection while patient's immune system is compromised by the treatment under the pharmaceuticals, all for use in risk management by physicians, pharmacists, and patients.
UK00910686021
Word
Individual